Pharma Journalist 8947 posts 0 comments

Accelerated Enrollment Solutions (AES), a business unit of Pharmaceutical Product Development, LLC (PPD), has acquired the clinical research site business of Bioclinica, expanding AES’…
Read More...

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, announced an…
Read More...

AstraZeneca announced that it has received marketing authorisation from China’s National Medical Products Administration (NMPA) for Tagrisso (osimertinib) as a 1st-line treatment for…
Read More...

BioMotiv, a mission-driven drug development accelerator that advances breakthrough discoveries from research institutions into therapeutics, and Bristol-Myers Squibb Company announced a…
Read More...

SMi Reports: Renowned industry experts to present on the Pre-Filled Syringes and Injectable Drugs Pre-Conference Workshop Day taking place in January 2020. SMi Group presents…
Read More...

Celltrion and Lonza announced a contract manufacturing agreement to produce drug substance for Remsima, a biosimilar approved by the EMA and the FDA for a number of autoimmune diseases…
Read More...

Allergan plc announced it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula…
Read More...

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system…
Read More...

Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into a global commercialization agreement for a proposed natalizumab biosimilar. The…
Read More...

Achilles Therapeutics, a biopharmaceutical company developing personalised cancer immunotherapies, announces it has closed a £100 million Series B financing led by incoming U.S.…
Read More...